TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT

癌症预防剂开发的技术信息研究资源

• 批准号: 8342779
• 负责人: CAROLINE C SIGMAN
• 金额: $ 177.93万
• 依托单位: CCS ASSOCIATES, INC.
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8342779
• 关键词: Agreement; Biological Products; Chemical Agents; Clinical; Clinical Trials; Confidentiality; Contracts; Data Reporting; Databases; Development; Documentation; Genomics; Industry; Information Management; Investigational New Drug Application; Literature; Malignant Neoplasms; Management Information Systems; Manuscripts; Medical; Office of Administrative Management; Pharmacologic Substance; Prevention Research; Preventive; Proteomics; Reporting; Research; Resources; Structure; abstracting; cancer prevention; meetings; pre-clinical; programs; research and development; technical report

The purpose of the contract is to provide a variety of critical cancer prevention research information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for investigational new drug (IND) applications to the FDA for clinical trials. Support for cancer preventive agent development includes the gathering and organizing of information from the research, pharmaceutical, and medical literature; preclinical and clinical technical project reports; scientific meetings; and private industry documents provided to the NCI under confidentiality agreements. Support also includes abstracting and maintaining data bases of technical reports; abstracting application materials for the PREVENT Cancer Program; preparing specific chemical and biological agent and general class documents and structure / function and genomic / proteomic informational and statistical analyses for the Management Administrative Committee (MAC); and drafting minutes of the External Steering Panel, the Special Emphasis Panel and MAC meetings and manuscripts of current topics, progress, and opportunities in cancer preventive agent development research.

该合同的目的是提供各种必要的关键癌症预防研究信息管理功能，以支持潜在癌症预防药物的识别，开发和资格认证，用于向FDA申请研究性新药（IND）进行临床试验。对癌症预防剂开发的支持包括收集和组织来自研究、制药和医学文献的信息;临床前和临床技术项目报告;科学会议;以及根据保密协议提供给NCI的私人行业文件。支助还包括：提取和维护技术报告的数据库;提取预防癌症方案的申请材料;为管理行政委员会编写具体的化学和生物制剂及一般类别文件以及结构/功能和基因组/蛋白质组信息和统计分析;起草外部指导小组、特别强调小组和MAC会议的会议记录，以及癌症预防剂开发研究的当前主题、进展和机会的手稿。